MannKind Corporation Company Profile (NASDAQ:MNKD)

About MannKind Corporation (NASDAQ:MNKD)

MannKind Corporation logoMannKind Corporation is a biopharmaceutical company. The Company is focused on the discovery and development of therapeutic products for diseases, such as diabetes. Its product candidate is AFREZZA, which is an inhaled insulin used to control high blood sugar in adults with type I and type II diabetes and helps in glycemic control. AFREZZA consists of a dry formulation of human insulin delivered from a portable inhaler. AFREZZA utilizes its Technosphere formulation technology. Technosphere is a drug delivery platform that may allow the oral inhalation of a range of therapeutics. Technosphere powders are based on the Company's fumaryl diketopiperazine (FDKP), which is a potential of Hydrogen (pH)-sensitive organic molecule that self-assembles into small particles under acidic conditions. The Company has also created a range of breath-powered, dry powder inhalers. Its inhalers can be produced in both a reusable (chronic treatment) and a single-use (acute treatment) format.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: Biotechnology
  • Symbol: NASDAQ:MNKD
  • CUSIP: 56400P20
  • Web: www.mannkindcorp.com
Capitalization:
  • Market Cap: $131.31 million
  • Outstanding Shares: 101,006,000
Average Prices:
  • 50 Day Moving Avg: $1.43
  • 200 Day Moving Avg: $1.18
  • 52 Week Range: $0.67 - $5.10
P/E:
  • Trailing P/E Ratio: 0.92
  • Foreward P/E Ratio: Infinity
  • P/E Growth: -0.05
Sales & Book Value:
  • Annual Revenue: $177.77 million
  • Price / Sales: 0.74
  • Book Value: ($2.08) per share
  • Price / Book: -0.63
Profitability:
  • EBIDTA: $65.91 million
  • Return on Equity: -23.44%
  • Return on Assets: 54.12%
Debt:
  • Debt-to-Equity Ratio: -0.39%
  • Current Ratio: 0.60%
  • Quick Ratio: 0.56%
Misc:
  • Average Volume: 3.71 million shs.
  • Beta: 3.33
  • Short Ratio: 8.31
 
Frequently Asked Questions for MannKind Corporation (NASDAQ:MNKD)

What is MannKind Corporation's stock symbol?

MannKind Corporation trades on the NASDAQ under the ticker symbol "MNKD."

How were MannKind Corporation's earnings last quarter?

MannKind Corporation (NASDAQ:MNKD) issued its earnings results on Wednesday, May, 10th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.09) by $0.08. The company had revenue of $3 million for the quarter, compared to analysts' expectations of $3.50 million. MannKind Corporation's revenue was up 2900.0% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.06) earnings per share. View MannKind Corporation's Earnings History.

Where is MannKind Corporation's stock going? Where will MannKind Corporation's stock price be in 2017?

2 analysts have issued twelve-month price targets for MannKind Corporation's stock. Their predictions range from $0.83 to $1.00. On average, they expect MannKind Corporation's share price to reach $0.92 in the next year. View Analyst Ratings for MannKind Corporation.

Are investors shorting MannKind Corporation?

MannKind Corporation saw a decline in short interest in the month of June. As of June 30th, there was short interest totalling 22,839,505 shares, a decline of 9.1% from the June 15th total of 25,118,910 shares. Based on an average trading volume of 2,504,553 shares, the days-to-cover ratio is presently 9.1 days. Currently, 37.8% of the shares of the company are short sold.

Who are some of MannKind Corporation's key competitors?

Who are MannKind Corporation's key executives?

MannKind Corporation's management team includes the folowing people:

  • Kent Kresa, Chairman of the Board
  • Michael E. Castagna Pharm.D., Chief Executive Officer, Director
  • Rosabel R. Alinaya, Acting Chief Financial Officer, Senior Vice President, Chief Accounting Officer
  • Linda Adreveno, Senior Vice President - Human Resources
  • Joseph Kocinsky, Chief Technology Officer, Corporate Vice President
  • David B. Thomson Ph.D., J.D., Corporate Vice President, General Counsel, Corporate Secretary
  • Raymond W. Urbanski M.D., Ph.D., Corporate Vice President, Chief Medical Officer
  • Stuart A. Tross Ph.D., Chief People Officer
  • James Samuel Shannon M.D., Director
  • Ronald J. Consiglio, Independent Director

How do I buy MannKind Corporation stock?

Shares of MannKind Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MannKind Corporation's stock price today?

One share of MannKind Corporation stock can currently be purchased for approximately $1.30.


MarketBeat Community Rating for MannKind Corporation (NASDAQ MNKD)
Community Ranking:  2.0 out of 5 ( )
Outperform Votes:  171 (Vote Outperform)
Underperform Votes:  263 (Vote Underperform)
Total Votes:  434
MarketBeat's community ratings are surveys of what our community members think about MannKind Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for MannKind Corporation (NASDAQ:MNKD) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Sell Ratings
Consensus Rating:Sell (Score: 1.00)
Consensus Price Target: $0.92 (29.62% downside)

Analysts' Ratings History for MannKind Corporation (NASDAQ:MNKD)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/22/2017J P Morgan Chase & CoReiterated RatingUnderweightHighView Rating Details
5/11/2017Piper Jaffray CompaniesSet Price TargetSell$1.00MediumView Rating Details
5/8/2017S&P Equity ResearchLower Price Target$1.04 -> $0.83HighView Rating Details
6/1/2016Royal Bank Of CanadaLower Price TargetUnderperform$1.00 -> $0.15N/AView Rating Details
4/28/2016JMP SecuritiesReiterated RatingHoldN/AView Rating Details
4/1/2016Goldman Sachs Group, Inc. (The)Reiterated RatingSellN/AView Rating Details
1/6/2016Griffin SecuritiesUpgradeNeutral -> Buy$4.00N/AView Rating Details
11/14/2015Jefferies Group LLCReiterated RatingBuy$9.00N/AView Rating Details
(Data available from 7/24/2015 forward)

Earnings

Earnings History for MannKind Corporation (NASDAQ:MNKD)
Earnings by Quarter for MannKind Corporation (NASDAQ:MNKD)
Earnings History by Quarter for MannKind Corporation (NASDAQ MNKD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/10/2017Q1 2017($0.09)($0.17)$3.50 million$3.00 millionViewN/AView Earnings Details
3/16/2017Q4 2016($0.20)($0.19)$6.00 million$12.40 millionViewN/AView Earnings Details
11/9/2016Q3 2016($0.06)$0.26$2.00 million$162.35 millionViewListenView Earnings Details
8/8/2016Q2($0.06)($0.07)$0.03 millionViewN/AView Earnings Details
5/9/2016Q116($0.04)($0.06)ViewN/AView Earnings Details
3/14/2016Q4($0.05)($0.66)$0.35 millionViewN/AView Earnings Details
11/9/2015Q315($0.07)($0.08)ViewN/AView Earnings Details
8/10/2015Q215($0.08)($0.07)$0.53 millionViewListenView Earnings Details
5/7/2015Q115($0.08)($0.08)$5.40 millionViewListenView Earnings Details
2/24/2015Q414($0.09)($0.09)$3.13 millionViewListenView Earnings Details
11/3/2014Q314$0.09($0.09)$66.60 millionViewListenView Earnings Details
8/11/2014Q214($0.11)($0.19)ViewListenView Earnings Details
5/12/2014Q114($0.13)($0.14)ViewListenView Earnings Details
2/18/2014Q4($0.14)($0.16)$0.43 millionViewListenView Earnings Details
11/4/2013Q313($0.14)($0.17)ViewListenView Earnings Details
8/9/2013Q2 2013($0.14)($0.16)ViewN/AView Earnings Details
5/9/2013Q1 2013($0.15)($0.15)ViewListenView Earnings Details
2/11/2013Q4 2012($0.19)($0.23)ViewListenView Earnings Details
11/1/2012Q312($0.24)($0.22)ViewN/AView Earnings Details
8/7/2012($0.24)($0.23)ViewN/AView Earnings Details
5/9/2012($0.23)($0.27)ViewN/AView Earnings Details
2/22/2012($0.32)($0.30)ViewN/AView Earnings Details
11/3/2011($0.32)($0.31)ViewN/AView Earnings Details
8/4/2011($0.30)($0.37)ViewN/AView Earnings Details
5/9/2011($0.29)($0.34)ViewN/AView Earnings Details
2/10/2011($0.40)($0.33)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for MannKind Corporation (NASDAQ:MNKD)
Current Year EPS Consensus Estimate: $-0.96 EPS

Dividends

Dividend History for MannKind Corporation (NASDAQ:MNKD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for MannKind Corporation (NASDAQ:MNKD)
Insider Ownership Percentage: 1.60%
Institutional Ownership Percentage: 17.73%
Insider Trades by Quarter for MannKind Corporation (NASDAQ:MNKD)
Institutional Ownership by Quarter for MannKind Corporation (NASDAQ:MNKD)
Insider Trades by Quarter for MannKind Corporation (NASDAQ:MNKD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/3/2017Matthew J PfefferCEOBuy4,540$0.54$2,451.60View SEC Filing  
1/3/2017Rosabel Realica AlinayaSVPBuy9,043$0.54$4,883.22View SEC Filing  
8/26/2016Michael CastagnaInsiderBuy17,500$0.78$13,650.00View SEC Filing  
8/24/2016Michael CastagnaInsiderBuy15,000$0.87$13,050.00View SEC Filing  
8/23/2016Michael CastagnaInsiderBuy25,000$0.94$23,500.00View SEC Filing  
8/15/2016Matthew J PfefferCEOBuy25,000$0.99$24,750.00View SEC Filing  
8/12/2016Michael CastagnaInsiderBuy25,000$1.00$25,000.00View SEC Filing  
5/17/2016Michael CastagnaInsiderBuy50,000$0.93$46,500.00View SEC Filing  
4/24/2015Hakan EdstromCEOSell73,460$4.83$354,811.80View SEC Filing  
3/27/2015Hakan EdstromCEOSell73,460$5.21$382,726.60View SEC Filing  
2/10/2015Hakan EdstromCEOSell73,460$7.75$569,315.00View SEC Filing  
2/5/2015David ThomsonVPSell80,000$7.00$560,000.00View SEC Filing  
1/5/2015Diane PalumboVPSell188,999$5.95$1,124,544.05View SEC Filing  
11/24/2014David ThomsonVPSell118,114$6.14$725,219.96View SEC Filing  
10/3/2014Juergen MartensVPSell63,800$5.48$349,624.00View SEC Filing  
8/27/2014Juergen MartensVPSell417$7.60$3,169.20View SEC Filing  
8/7/2014David ThomsonVPSell30,000$8.16$244,800.00View SEC Filing  
7/21/2014Juergen MartensVPSell26,458$9.65$255,319.70View SEC Filing  
7/15/2014Diane PalumboVPSell17,901$10.01$179,189.01View SEC Filing  
7/1/2014Matthew J PfefferCFOSell20,000$10.44$208,800.00View SEC Filing  
6/30/2014Hakan EdstromCOOBuy1,692$4.42$7,478.64View SEC Filing  
6/27/2014Juergen MartensVPSell25,417$10.53$267,641.01View SEC Filing  
6/26/2014David ThomsonVPSell30,000$10.51$315,300.00View SEC Filing  
6/20/2014Juergen MartensVPSell1,458$10.34$15,075.72View SEC Filing  
6/16/2014Diane PalumboVPSell17,902$10.59$189,582.18View SEC Filing  
6/5/2014Juergen MartensVPSell120,000$11.00$1,320,000.00View SEC Filing  
6/4/2014David ThomsonVPSell133,000$9.95$1,323,350.00View SEC Filing  
6/3/2014Diane PalumboVPSell52,957$9.50$503,091.50View SEC Filing  
5/23/2014Juergen MartensVPSell25,000$7.65$191,250.00View SEC Filing  
5/19/2014Juergen MartensVPSell76,899$7.50$576,742.50View SEC Filing  
5/15/2014Diane PalumboVPSell18,176$7.06$128,322.56View SEC Filing  
1/24/2014Juergen MartensVPSell50,000$5.56$278,000.00View SEC Filing  
12/31/2013Hakan EdstromCOOBuy1,589$4.53$7,198.17View SEC Filing  
12/20/2013Juergen MartensVPSell32,054$5.00$160,270.00View SEC Filing  
12/11/2013David ThomsonVPSell150,000$5.00$750,000.00View SEC Filing  
11/29/2013Juergen MartensVPSell48,057$5.01$240,765.57View SEC Filing  
11/15/2013Diane PalumboVPSell25,000$5.02$125,500.00View SEC Filing  
8/28/2013David ThomsonVPSell19,204$5.78$110,999.12View SEC Filing  
8/26/2013Juergen MartensVPSell20,000$5.52$110,400.00View SEC Filing  
8/1/2013Matthew J PfefferCFOSell10,000$8.00$80,000.00View SEC Filing  
7/2/2013Matthew J PfefferCFOSell10,000$7.00$70,000.00View SEC Filing  
6/30/2013Diane PalumboVPBuy1,610$1.96$3,155.60View SEC Filing  
6/30/2013Matthew J PfefferCFOBuy7,448$1.96$14,598.08View SEC Filing  
6/3/2013Diane PalumboVPSell66,849$7.50$501,367.50View SEC Filing  
5/16/2013Diane PalumboVPSell26,829$5.25$140,852.25View SEC Filing  
5/15/2013Matthew J PfefferCFOSell10,000$5.00$50,000.00View SEC Filing  
12/31/2012Matthew J PfefferCFOBuy1,056$1.95$2,059.20View SEC Filing  
12/21/2012Alfred E MannMajor ShareholderBuy40,000,000$2.59$103,600,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for MannKind Corporation (NASDAQ:MNKD)
Latest Headlines for MannKind Corporation (NASDAQ:MNKD)
Source:
DateHeadline
streetinsider.com logoMannKind (MNKD) Names Steven Binder as CFO
www.streetinsider.com - July 18 at 11:35 PM
finance.yahoo.com logoSteven Binder Joins MannKind as Chief Financial Officer
finance.yahoo.com - July 17 at 10:20 AM
americanbankingnews.com logoMannKind Corporation (MNKD) Short Interest Down 9.1% in June
www.americanbankingnews.com - July 16 at 7:12 AM
finance.yahoo.com logoToday's Research Reports on Stocks to Watch: Mannkind Corporation and AstraZeneca
finance.yahoo.com - July 15 at 6:31 AM
finance.yahoo.com logoOptions Traders Expect Huge Moves in MannKind (MNKD) Stock - Yahoo Finance
finance.yahoo.com - July 14 at 6:31 AM
finance.yahoo.com logoOptions Traders Expect Huge Moves in MannKind (MNKD) Stock
finance.yahoo.com - July 14 at 6:31 AM
finance.yahoo.com logoPatrick McCauley Joins MannKind as Chief Commercial Officer
finance.yahoo.com - July 13 at 6:52 AM
seekingalpha.com logoMannKind: Weekly Afrezza Scripts Leveling Off Above 300 - Seeking Alpha
seekingalpha.com - July 9 at 7:20 PM
reuters.com logoBRIEF-Mannkind renegotiates near-term maturities with Deerfield
www.reuters.com - July 1 at 9:06 PM
seekingalpha.com logoMannKind Maxes Out Its Last Credit Card - Seeking Alpha
seekingalpha.com - June 30 at 1:41 AM
seekingalpha.com logoMannKind Renegotiates Debt Payment To Deerfield - Seeking Alpha
seekingalpha.com - June 30 at 1:41 AM
finance.yahoo.com logoMannKind Renegotiates Near-Term Maturities with Deerfield
finance.yahoo.com - June 30 at 1:41 AM
streetinsider.com logoMannKind (MNKD) Draws Remaining Funds Pursuant to Terms of Mann Group Loan Arrangement - StreetInsider.com
www.streetinsider.com - June 28 at 10:07 AM
finance.yahoo.com logoMannKind Draws Remaining Funds under Mann Group Loan Arrangement
finance.yahoo.com - June 28 at 10:07 AM
seekingalpha.com logoMannKind: Afrezza Sales See Best Result In More Than A Year ... - Seeking Alpha
seekingalpha.com - June 26 at 12:15 AM
seekingalpha.com logoMannKind: Afrezza Scripts Above 300 - Can Sales Keep Climbing? - Seeking Alpha
seekingalpha.com - June 20 at 7:36 PM
seekingalpha.com logoA Medical Doctor's Perspective On MannKind Corp.'s Revolutionary Diabetes Mellitus Treatments
seekingalpha.com - June 17 at 7:22 PM
finance.yahoo.com logoIs the Options Market Predicting a Spike in MannKind (MNKD) Stock?
finance.yahoo.com - June 16 at 7:33 PM
seekingalpha.com logoMannKind Scripts Not Helping Cash Situation - Seeking Alpha
seekingalpha.com - June 14 at 10:14 PM
americanbankingnews.com logoMannKind Co. (MNKD) Short Interest Update
www.americanbankingnews.com - June 11 at 7:26 AM
finance.yahoo.com logoMannKind Engages Locust Walk to Explore Strategic Options for MannKind’s Non-insulin Technosphere-based Pipeline Candidates
finance.yahoo.com - June 5 at 9:17 AM
americanbankingnews.com logoMannKind Co. (MNKD) Downgraded by ValuEngine to Hold
www.americanbankingnews.com - June 4 at 7:43 AM
nasdaq.com logoMannKind and Biomm Enter Into Distribution Agreement for Afrezza in Brazil - Nasdaq
www.nasdaq.com - May 31 at 6:57 PM
feeds.benzinga.com logoMannKind and Biomm Enter Into Distribution Agreement for Afrezza in Brazil
feeds.benzinga.com - May 31 at 6:06 PM
globenewswire.com logoMannKind Provides Update on Senior Management - GlobeNewswire (press release)
globenewswire.com - May 31 at 8:16 AM
finance.yahoo.com logoMannKind Corporation (MNKD) Catches Eye: Stock Jumps 7%
finance.yahoo.com - May 30 at 10:02 AM
finance.yahoo.com logoMannKind Provides Update on Senior Management
finance.yahoo.com - May 30 at 10:02 AM
americanbankingnews.com logoMannKind Co. (MNKD) Sees Large Growth in Short Interest
www.americanbankingnews.com - May 26 at 7:53 AM
americanbankingnews.com logoJPMorgan Chase & Co. Reaffirms Underweight Rating for MannKind Co. (MNKD)
www.americanbankingnews.com - May 22 at 10:54 AM
seekingalpha.com logoReading MannKind's SEC Documents Would Help Investors Preserve Their Capital - Seeking Alpha
seekingalpha.com - May 19 at 11:15 AM
nasdaq.com logoHealth Care Sector Update for 05/16/2017: MNKD,AKBA,FMS,ETRM - Nasdaq
www.nasdaq.com - May 18 at 8:26 AM
americanbankingnews.com logoMannKind Co. (MNKD) Earns "Sell" Rating from JPMorgan Chase & Co.
www.americanbankingnews.com - May 13 at 6:26 PM
americanbankingnews.com logoMannKind Co. (MNKD) Given a $1.00 Price Target by Piper Jaffray Companies Analysts
www.americanbankingnews.com - May 13 at 6:26 PM
seekingalpha.com logoMannKind Corp.: Nothing But Losses - Seeking Alpha
seekingalpha.com - May 12 at 7:12 PM
seekingalpha.com logoMannKind Reports Q1 Loss - What Investors Need To Know - Seeking Alpha
seekingalpha.com - May 11 at 7:05 PM
nasdaq.com logoImplied Volatility Surging for MannKind Corporation (MNKD) Stock Options - Nasdaq
www.nasdaq.com - May 11 at 7:05 PM
finance.yahoo.com logoImplied Volatility Surging for MannKind Corporation (MNKD) Stock Options
finance.yahoo.com - May 11 at 7:05 PM
finance.yahoo.com logoHere's Why MannKind Corporation Stock Is Tanking Today
finance.yahoo.com - May 11 at 7:05 PM
fool.com logoHere's Why MannKind Corporation Stock Is Tanking Today
www.fool.com - May 11 at 4:16 PM
investorplace.com logoMannKind Corporation (MNKD) Stock Slammed Despite Smaller Q1 Losses
investorplace.com - May 11 at 11:43 AM
seekingalpha.com logoMannKind Q1 revenue disappoints, shares down 15%
seekingalpha.com - May 11 at 11:20 AM
seekingalpha.com logoMannKind's (MNKD) CEO Matthew Pfeffer on Q1 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 11 at 7:00 AM
finance.yahoo.com logoEdited Transcript of MNKD earnings conference call or presentation 10-May-17 9:00pm GMT
finance.yahoo.com - May 11 at 6:59 AM
americanbankingnews.com logoMannKind Co. (MNKD) Announces Quarterly Earnings Results, Misses Estimates By $0.29 EPS
www.americanbankingnews.com - May 10 at 11:48 PM
marketwatch.com logo10-Q: MANNKIND CORP
www.marketwatch.com - May 10 at 6:41 PM
finance.yahoo.com logoMannKind Corporation Reports 2017 First Quarter Financial Results
finance.yahoo.com - May 10 at 6:41 PM
finance.yahoo.com logoMannKind reports 1Q loss
finance.yahoo.com - May 10 at 6:41 PM
investorplace.com logoMannKind Corporation (MNKD) Shares Continue to Surge on ‘One Drop’ News
investorplace.com - May 10 at 1:20 PM
investorplace.com logoMannKind Corporation (MNKD) Shares Continue to Surge on ‘One Drop’ News
investorplace.com - May 10 at 1:10 PM
finance.yahoo.com logoInvestor Network: MannKind Corporation to Host Earnings Call
finance.yahoo.com - May 10 at 12:20 PM

Social

Chart

MannKind Corporation (MNKD) Chart for Monday, July, 24, 2017

This page was last updated on 7/24/2017 by MarketBeat.com Staff